FRESENIUS MEDICAL CARE AG (FME.DE) Fundamental Analysis & Valuation

FRA:FME • DE0005785802

Current stock price

38.75 EUR
-0.09 (-0.23%)
Last:

This FME.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FME.DE Profitability Analysis

1.1 Basic Checks

  • In the past year FME was profitable.
  • FME had a positive operating cash flow in the past year.
  • In the past 5 years FME has always been profitable.
  • Each year in the past 5 years FME had a positive operating cash flow.
FME.DE Yearly Net Income VS EBIT VS OCF VS FCFFME.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • FME's Return On Assets of 3.16% is fine compared to the rest of the industry. FME outperforms 74.07% of its industry peers.
  • Looking at the Return On Equity, with a value of 7.35%, FME is in line with its industry, outperforming 55.56% of the companies in the same industry.
  • FME's Return On Invested Capital of 5.30% is in line compared to the rest of the industry. FME outperforms 59.26% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for FME is in line with the industry average of 5.73%.
  • The last Return On Invested Capital (5.30%) for FME is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
FME.DE Yearly ROA, ROE, ROICFME.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 4.98%, FME is doing good in the industry, outperforming 77.78% of the companies in the same industry.
  • In the last couple of years the Profit Margin of FME has declined.
  • With a decent Operating Margin value of 9.00%, FME is doing good in the industry, outperforming 70.37% of the companies in the same industry.
  • FME's Operating Margin has declined in the last couple of years.
  • FME's Gross Margin of 25.62% is in line compared to the rest of the industry. FME outperforms 51.85% of its industry peers.
  • In the last couple of years the Gross Margin of FME has declined.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
FME.DE Yearly Profit, Operating, Gross MarginsFME.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5

2. FME.DE Health Analysis

2.1 Basic Checks

  • FME has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, FME has less shares outstanding
  • The number of shares outstanding for FME has been reduced compared to 5 years ago.
  • Compared to 1 year ago, FME has a worse debt to assets ratio.
FME.DE Yearly Shares OutstandingFME.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
FME.DE Yearly Total Debt VS Total AssetsFME.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.82 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of FME (1.82) is better than 62.96% of its industry peers.
  • FME has a debt to FCF ratio of 6.19. This is a slightly negative value and a sign of low solvency as FME would need 6.19 years to pay back of all of its debts.
  • FME's Debt to FCF ratio of 6.19 is fine compared to the rest of the industry. FME outperforms 74.07% of its industry peers.
  • FME has a Debt/Equity ratio of 0.65. This is a neutral value indicating FME is somewhat dependend on debt financing.
  • FME has a Debt to Equity ratio of 0.65. This is amongst the best in the industry. FME outperforms 81.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 1.82
ROIC/WACC1.05
WACC5.06%
FME.DE Yearly LT Debt VS Equity VS FCFFME.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • FME has a Current Ratio of 1.26. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
  • FME has a better Current ratio (1.26) than 62.96% of its industry peers.
  • A Quick Ratio of 0.92 indicates that FME may have some problems paying its short term obligations.
  • FME has a Quick ratio (0.92) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
FME.DE Yearly Current Assets VS Current LiabilitesFME.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

5

3. FME.DE Growth Analysis

3.1 Past

  • FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.00%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -1.51% on average over the past years.
  • The Revenue has been growing slightly by 1.51% in the past year.
  • The Revenue has been growing slightly by 1.91% on average over the past years.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%

3.2 Future

  • FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.50% yearly.
  • The Revenue is expected to grow by 3.16% on average over the next years.
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y8.5%
Revenue Next Year-0.88%
Revenue Next 2Y1.45%
Revenue Next 3Y2.08%
Revenue Next 5Y3.16%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FME.DE Yearly Revenue VS EstimatesFME.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FME.DE Yearly EPS VS EstimatesFME.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

7

4. FME.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.03, which indicates a very decent valuation of FME.
  • 88.89% of the companies in the same industry are more expensive than FME, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of FME to the average of the S&P500 Index (27.35), we can say FME is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.41, which indicates a very decent valuation of FME.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FME indicates a rather cheap valuation: FME is cheaper than 96.30% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.23. FME is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.03
Fwd PE 9.41
FME.DE Price Earnings VS Forward Price EarningsFME.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, FME is valued cheaply inside the industry as 81.48% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of FME indicates a rather cheap valuation: FME is cheaper than 81.48% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.52
EV/EBITDA 6.03
FME.DE Per share dataFME.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.59%
EPS Next 3Y5.97%

7

5. FME.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.82%, FME has a reasonable but not impressive dividend return.
  • FME's Dividend Yield is rather good when compared to the industry average which is at 1.64. FME pays more dividend than 96.30% of the companies in the same industry.
  • FME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.82%

5.2 History

  • The dividend of FME has a limited annual growth rate of 4.43%.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years3
FME.DE Yearly Dividends per shareFME.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • FME pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.19%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
FME.DE Yearly Income VS Free CF VS DividendFME.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
FME.DE Dividend Payout.FME.DE Dividend Payout, showing the Payout Ratio.FME.DE Dividend Payout.PayoutRetained Earnings

FME.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS MEDICAL CARE AG

FRA:FME (4/27/2026, 7:00:00 PM)

38.75

-0.09 (-0.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners44.85%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.37B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target45.41 (17.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.82%
Yearly Dividend1.48
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-0.82%
PT rev (3m)-4.5%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)29.21%
EPS NY rev (1m)2.65%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.93%
Revenue NY rev (1m)-1.61%
Revenue NY rev (3m)-3.66%
Valuation
Industry RankSector Rank
PE 9.03
Fwd PE 9.41
P/S 0.58
P/FCF 6.52
P/OCF 4.24
P/B 0.85
P/tB N/A
EV/EBITDA 6.03
EPS(TTM)4.29
EY11.07%
EPS(NY)4.12
Fwd EY10.62%
FCF(TTM)5.94
FCFY15.34%
OCF(TTM)9.14
OCFY23.58%
SpS66.89
BVpS45.36
TBVpS-5.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number66.1712 (70.76%)
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 1.82
F-Score8
WACC5.06%
ROIC/WACC1.05
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y8.5%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year-0.88%
Revenue Next 2Y1.45%
Revenue Next 3Y2.08%
Revenue Next 5Y3.16%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year70.62%
EBIT Next 3Y23.59%
EBIT Next 5Y14.58%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE AG / FME.DE Fundamental Analysis FAQ

What is the fundamental rating for FME stock?

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.


What is the valuation status for FME stock?

ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.


How profitable is FRESENIUS MEDICAL CARE AG (FME.DE) stock?

FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for FME stock?

The financial health rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 5 / 10.


How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?

The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 43.19%.